WallStreetZenWallStreetZen

NASDAQ: PHAT
Phathom Pharmaceuticals Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Phathom Pharmaceuticals earnings were -$99.1M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest PHAT earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$17.6M, down 42.1% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, PHAT reported annual earnings of -$221.2M, with -33.8% growth.

PHAT earnings history

Current Revenue
$239.7M
Current Earnings
-$99.1M
Current Profit Margin
-41.3%

PHAT Return on Equity

Insufficient data to display

PHAT Return on Assets

Current Company
-35%
Current Industry
-3.2%
PHAT is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when PHAT announces earnings.

PHAT Return on Capital Employed

Current Company
-20.57%
Current Industry
-1.8%
PHAT has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

PHAT vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
PHAT-$35.14M-$99.07MN/A-$1.26
PHAR$31.74M$10.57M-22.56%$0.16
OCS-$119.94M-$121.28MN/A-$2.19
KZIAN/A-$16.17MN/A-$1.51
AURA-$109.59M-$112.39MN/A-$1.74
View Top Biotech Stocks

Phathom Pharmaceuticals Earnings Reports & History FAQ

What were Phathom Pharmaceuticals's earnings last quarter?

On PHAT's earnings call on Jul 30, 2026, Phathom Pharmaceuticals (NASDAQ: PHAT) reported Q2 2026 earnings per share (EPS) of -$0.21, up 80% year over year. Total PHAT earnings for the quarter were -$17.58 million. In the same quarter last year, Phathom Pharmaceuticals's earnings per share (EPS) was -$1.05.

If you're new to stock investing, here's how to buy Phathom Pharmaceuticals stock.

Is Phathom Pharmaceuticals profitable or losing money?

As of the last Phathom Pharmaceuticals earnings report, Phathom Pharmaceuticals is currently losing money. Phathom Pharmaceuticals's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$99.07 million, a 69.99% decrease year over year.

What was PHAT's earnings growth in the past year?

As of Phathom Pharmaceuticals's earnings date in Jul 30, 2026, Phathom Pharmaceuticals's earnings has grown year over year. PHAT earnings in the past year totalled -$99.07 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.